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Background
The presence of comorbid psychopathology in substance
abusers is of considerable clinical interest. Psychiatric ill-
ness may serve as a risk factor for substance abuse,
develop as a result of chronic substance abuse, or alter the
course, prognosis, and outcome of substance abuse. A fac-
tor which leads to treatment failure and re-use of sub-
stances is to ignore mental disorders before and after
detoxification. The aim of this study is comparison
between anxiety and depression scores before and after
detoxification, and whether or not should anxiolytic and
antidepressant drugs be prescribed.
Materials and methods
70 opium-addicted cases referred to a detoxification cen-
tre in Esfahan were selected by easy method of sampling
and evaluated for depression (with "Beck" test) and anxi-
ety (with "Zung" test), in three times (admittance time,
the first visit after detoxification, and a month later).
Treatment type was "Methadone Assisted Detoxification".
P values less than 0.05 were considered meaningful.
Results
The average of anxiety scores at the admittance time was
38.85; immediately after detoxification, 34.97; and a
month after detoxification, 30.72. The average of depres-
sion scores in those times were 26.65, 19, and 16.38,
respectively.
Discussion
The anxiety and depression average scores in admittance
time and in the first visit after detoxification had meaning-
ful differences. Therefore, anxiety and depression symp-
toms decrease during addiction treatment, and it is not
needed to use anxiolytic and antidepressant drugs rou-
tinely over treatment process.
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